What You Ought to Know:
– Verantos, the chief in high-quality real-world proof (RWE) kinds a strategic partnership with CuriMeta to develop Verantos’ Analysis Community with de-identified information from 7 million sufferers,
– The collaboration will improve the depth and attain of real-world information (RWD) obtainable to life science organizations.
Enhancing RWD High quality and Accessibility
The Verantos Analysis Community is a novel platform that gathers information from varied sources, together with tutorial establishments, group well being techniques, insurance coverage claims, and illness registries. Their concentrate on high-quality information ensures researchers have entry to essentially the most dependable and complete RWD obtainable.
The 2 firms will collaborate throughout varied therapeutic areas. CuriMeta’s information will instantly assist the event and growth of Verantos’ disease-specific Pragmatic Registries, in the end resulting in simpler remedies and improved affected person outcomes.
“The Verantos Proof Platform makes use of synthetic intelligence (AI) to generate distinctive disease-specific insights. It’s important that AI fashions are skilled utilizing high-quality affected person care information,” mentioned Anand Shroff, President of Verantos. “CuriMeta’s participation will allow us to reinforce our disease-specific Pragmatic Registries which are used to speed up life sciences analysis.”